Outcome of Board Meeting

July 30, 2026 Ref: NIVABUPA/EQ/2026-27/26 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Dalal Street, Bandra (E), Mumbai – 400 051 Mumbai – 400 001 Symbol: NIVABUPA Scrip Code: 544286 Sub: Outcome of the Board Meeting held on July 30, 2026 Ref: Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Dear Sir/Madam, We hereby inform you that the Board of Directors (‘the Board’) of the Company, at its meeting held today i.e. on Thursday, July 30, 2026, inter-alia, have considered and approved the following: - Based on the recommendation of the Audit Committee, Unaudited financial results of the Company for the quarter ended June 30, 2026. A copy of the said results along with limited review report issued by Joint Statutory Auditors thereon, is enclosed herewith as Annexure-I. - Fund raising by way of issuance of listed, rated, unsecured, subordinated, redeemable, non- convertible debentures of upto ₹500.00 crores (Indian Rupees Five Hundred Crores only) in one or more tranches, on a private placement basis in accordance with applicable laws. The Board has constituted its subcommittee, namely, Debt Raising Committee (‘DRC’), to determine and finalize the terms and conditions of issuance and allotment. The details as required under SEBI Master Circular no. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026, is enclosed herewith as Annexure-II. The Meeting of the Board commenced at 03:00 P.M. (IST) and concluded at 03:45 P.M. (IST). Kindly take the same on records. Thanking you, Yours Sincerely, For Niva Bupa Health Insurance Company Limited Aparna Sharma Company Secretary and Compliance Officer Niva Bupa Health Insurance Company Limited IRDAI Registration No. 145 | CIN: L66000DL2008PLC182918 Registered Office: C-98, First Floor, Lajpat Nagar, Part 1, Delhi-110024 Corporate Office: 3rd Floor, Capital Cyber scape, Golf Course Extension Road, Sector-59, Gurugram-122101, Haryana. Website: www.nivabupa.com | Email id: investor@nivabupa.com I Tel: +91-124-6354900 S.R. Batliboi & Co. LLP Nangia & Co LLP Chartered Accountants Chartered Accountants 12th Floor, The Ruby, A-109, Sector 136, 29 Senapati Bapat Marg, Noida - 201304 Dadar (West), Mumbai- 400 028 India Telephone +91 22 6819 8000 Telephone +91 120 2598000 the Regulation 33 and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended Review Report to The Board of Directors Niva Bupa Health Insurance Company Limited 1. We have reviewed the accompanying statement of unaudited financial results of Niva Bupa Health Insurance Company Limited for the quarter ended June 30, 2026 , being submitted by the Company pursuant to the requirement of Regulation 33 and Regulation 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including relevant circulars issued by the SEBI IRDAI ) circular reference IRDAI/F&I/CIR/MISC/92/7/2026 dated July 8, 2026. This Statement is the responsibility of the Company's Management and has been approved by the Board of Directors. Our responsibility is to express a conclusion on the Statement based on our review. 2. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review is limited primarily to inquiries of Company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. 3. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement prepared in accordance with the requirements of, the recognition and measurement principles laid down in Indian Accounting Standard Ind AS 34 prescribed under section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India, to the extent applicable and the accounting and presentation principles as prescribed in the relevant provisions of the Insurance Act, 1938 as amended by the Insurance Laws (Amendment) Act, 2015 (the "Insurance Act"), the Insurance Regulatory and Development Authority Act, 1999 (the "IRDA Act") and the Insurance Regulatory and Development Authority of India (Actuarial, Finance and Investment Functions of Insurers) Regulations, 2024 read with Master Circular No. IRDAI/ACTL/CIR/MISC/80/05/2024 dated May 17, 2024, the Insurance Regulatory and Development Authority (Actuarial, Finance and Investment Functions of Insurers), (Amendment) Regulations, 2026 and Circular No. issued by the IRDAI to the extent applicable in the manner so required, as amended from time to time, has not disclosed the information required to be disclosed in terms of Regulation 33 and Regulation 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and IRDAI circular reference IRDAI/F&I/CIR/MISC/92/7/2026 dated July 8, 2026, to the extent applicable, including the manner in which it is to be disclosed, or that it contains any material misstatement. Emphasis of Matter 4. As discussed in Note 6 to the Statement, the Company has filed an application for forbearance of the Expenses exceeding over the allowable limit as per IRDAI (Expenses of Management, including Commission, of insurers) Regulation, 2024 in respect of financial year 2024-25 with IRDAI, approval for which is yet to be received. Pending grant of forbearance by IRDAI, the consequential impact, if any, of the above on the statements cannot be presently determined. Our Conclusion is not modified in respect of this matter. S.R. Batliboi & Co. LLP Nangia & Co LLP Chartered Accountants Chartered Accountants 12thFloor, The Ruby, A-109, Sector 136, 29 Senapati Bapat Marg, Noida -201304 Dadar (West), Mumbai-400 028 India Telephone+91 22 6819 8000 Telephone +91 1202598000 Other Matter 5. The comparative Ind AS financial information appearing in the accompanying results for the corresponding quarterended June30, 2025included in these Ind AS financial results of the Company, is based on the previously issued financial information, prepared in accordance with the accounting standards specified under section 133 of the Companies Act, 2013, read with the Companies (Accounting Standards) Rules, 2021and other accounting principles generally accepted in India and the relevant provisions of the Insurance Act, the IRDA Act and the IRDAI Regulations and orders/directions/circulars issued by the IRDAIto the extent applicable in the manner so required,as amended from time to timeand reviewedby one of the joint auditors i.e. S.R. Batliboi & Co. LLP and one of the predecessor auditors i.e. T.R. Chadha & Co. LLP whoexpressed an unmodified conclusiondated July 31, 2025as adjusted for the differences in the accounting principles adopted by the Company on transition to the Ind AS,which have been prepared and presented based on the information compiled by the management. For S.R. Batliboi & Co. LLP ForNangia & Co LLP Chartered Accountants Chartered Accountants FRN No.301003E/E300005 FRN No. 002391C/N500069 Shrawan Digitally signed by Shrawan Bhagwati Jalan Bhagwati DN: cn=Shrawan Bhagwati Jalan, c=IN, o=Personal Jalan Date: 2026.07.30 15:42:22 +05'30' per Shrawan Jalan Vikas Gupta Partner Partner Membership No. 102102 Membership No. 076879 UDIN:26102102UNEROU3147 UDIN:26076879JXJOKO7963 Place: Mumbai Place: Noida Date: July 30, 2026 Date: July 30, 2026 Annexure II Sr. no. Particular(s) Detail(s) 1. Type of securities proposed t [Showing first 8,000 characters — download PDF for full document]